| |
| 長村 義之 |
国際医療福祉大学大学院教授 |
| |
| HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity. Hanna WM, Ruschoff J, Bilous M, Coudry RA, Dowsett M, Osamura RY, Penault-Llorca F, van de Vijver M, Viale G: Mod Pathol 2013. in press |
| Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution. Osamura RY, Egashira N, Kajiya H, Takei M, Tobita M, Miyakoshi T, Inomoto C, Takekoshi S, Teramoto A: Acta Histochem Cytochem 2009, 42:95-104. |
| Her2 Testing in Gastric Cancer: A Practical Approach. Ruschoff J, Hanna W, Bilous M, Hofmann M, Osamura RY, Penault-Llorca F, et al. Mod Pathol 2012, 25:637-50 |
|
| ○ |
| 北島 政樹 |
国際医療福祉大学・学長 |
| 消化器外科 |
| Masaki Kitajima, Yuko Kitagawa: Surgical Treatment of Esophageal Cancer- The Advent of the Era of Individualization. The New England Journal of Medicine 347(21):1705-1708, 2002 |
| Hiroshi Yagi, Masakazu Ueda, Hiromitsu Jinnno, Koichi Aiura, Shuji Mikami, Hiroko Tada, Masaharu Seno, Hidenori Yamada and Masaki Kitajima: Anti-tumor effect in an in vivo model by human-derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic properties. Cancer Science 97(12):1315-1320, 2006 |
| Hiroya Takeuchi, MD, Hirohumi Fujii, MD, Nobutoshi Ando, MD, Soji Ozawa, MD, Yoshiro Saikawa, MD, Koichi Suda, MD, Takashi Oyama, MD, Makio Mukai, MD, Tadaki Nakahara, MD, Atsushi Kubo, MD, Masaki Kitajima, MD, and Yuko Kitagawa, MD: Validation Study of Radio-Guided Sentinel Lymph Node Navigation in Esophageal Cancer: Annals of Surgery/Volume 249, p757-762: Number 5, May 2009 |
|
| |
| 児玉 哲郎 |
栃木県立がんセンタ-所長 |
| 臨床腫瘍学、呼吸器診断学 |
| Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis. Yokozaki M, Kodama T, et al. : Modern Pathol, 9:1156-1164, 1996 |
Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma. Miyake Y, Kodama T, Yamaguchi K: Cancer Res, 54:2136-2140, 1994 |
| Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Sugano K, Kodama T, et al. Cancer Sci 99:1967-1976, 2008 |
|
| |
| 高嶋 成光 |
(独)国立病院機構 四国がんセンター 名誉院長 |
| 乳腺外科 |
| Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer:A randomized,placebo-controlled trial. Kohno N, Aogi K,Takashima S,et al. J Clin Oncol 23:3314-3321,2005. |
Randomized trial of cyclophosphamide,epirubicin,and fluorouracil chemotherapy compared with cyclophosphamide,methotrexate,and fluorouracil with node-positive breast cancer in Japan. Kimura M,
Tominaga Y, Takashima S,et al. Breast Cancer 17:190-198,2010. |
| Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer. Ohsumi S, Inoue T, Takashima S,et al. Breast Cancer Res Treat 130:267-272,2011. |
|
| |
| 田村 和夫 |
福岡大学医学部腫瘍・血液・感染症内科学教授 |
| 臨床腫瘍学 |
Prognostic index for acute- and lymphoma-type adult T-cell leukemia/
lymphoma. Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H,
Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N,
Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H,
Jo T, Suzumiya J, Tamura K: J Clin Oncol. 30(14): 1635-40, 2012
|
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult
T-cell leukemia/lymphoma: a multicenter phase II study. Takamatsu Y,
Suzumiya J, Utsunomiya A, Maeda K, Matsuoka H, Suzushima H, Tsukada J,
Shibata K, Tamura K; the Kyushu Hematology Organization for Treatment
Study Group (K-HOT). Eur J Haematol. 84(5): 391-7, 2010 |
| Pilot study of Irinotecan and S-1 for advanced and metastatic breast cancer. Tanaka M, Furusawa H, Kamada Y, Sagara Y, Anan K, MiyaraK, Kai Y, Wakamatsu S, Uga T, Tamura K, Mitsuyama S, Kyushu Breast Cancer Study Group. San Antonio Breast Cancer Symposium 2010 |
|
| |
| 鶴丸 昌彦 |
順天堂大学がん治療センター長 特任教授 |
| 消化器外科、 |
| Frequency and Localization of Lymphatic Spread in Squamous Cell Carcinoma. Masahiko Tsurumaru. 7th World Congress of ISDE, Montreal, Canada, 1998 |
| Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: Algorithm for risk of nodal metastasis based on lymphatic invasion. N Tomita, T Matsumoto, T Hayashi, A Arakawa, H Sonoue, Y Kajiyama, M Tsurumaru. Pathology International. 58:282-287, 2008 |
Three-Field Esophagectomy: ADULT CHEST SURGERY (Editor: DJ Sugarbaker):171-182, McGraw Hill(2009)
M Tsurumaru, Y Kajiyama, Y Iwanuma, H Udagawa, H Akiyama.(査読なし) |
|
| |
| 根本 建二 |
山形大学医学部教授 |
| 放射線腫瘍学 |
| Influence of a multidisciplinary cancer board on treatment decisions. Nemoto K, Murakami M, Ichikawa M, Ohta I, Nomiya T, Yamakawa M, Itho Y, Fukui T, Yoshioka T. Int J Clin Oncol. 2012 May; in press (online journal available). |
Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection. Nemoto K, Takai K, Ogawa Y, Sakayauchi T, Sugawara T, Jingu K, Wada H, Takai Y, Yamada S.
Int J Radiat Oncol Biol Phys. 2005 Dec;63(5):1290-1294. |
| Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods. Nemoto K, Yamada S, Hareyama M, Nagakura H, Hirokawa Y.Int J Radiat Oncol Biol Phys. 2001 Jul;50(3):639-644. |
|
| |
| 原 純一 |
大阪市立総合医療センター 副院長 |
| 小児血液学・腫瘍学 |
Development of treatment strategies for advanced neuroblastoma.
Hara J.
Int J Clin Oncol. 2012 Jun;17(3):196-203. |
| Rutkowski S, Cohen B, Finlay J, Luksch R, Ridola V, Valteau-Couanet D, Hara J, Garre ML, Grill J. Medulloblastoma in young children. Pediatr Blood Cancer. 2010 Apr;54(4):635-7 |
| Hara J, Benedict SH, Yumura K, Ha-Kawa K, Gelfand EW: Rearrangement of variable region T cell receptor gamma genes in acute lymphoblastic leukemia. V gamma gene usage differs in mature and immature T cells.J Clin Invest 1989;83(4):1277-1283 |
|
